Rui Jiang
Corporate Secretary chez JINKO SOLAR CO., LTD.
Profil
Rui Jiang currently works at Cali Biosciences Co. Ltd., as Non-Executive Director from 2021 and Jinko Solar Co., Ltd., as Secretary from 2021.
Mr. Jiang also formerly worked at Bloomage Biotechnology Corp.
Ltd., as Board Secretary, Director & Deputy General Manager from 2019 to 2020.
Mr. Jiang received his graduate degree in 2008 from Renmin University of China.
Postes actifs de Rui Jiang
Sociétés | Poste | Début |
---|---|---|
JINKO SOLAR CO., LTD. | Corporate Secretary | 07/01/2021 |
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Director/Board Member | 17/03/2021 |
Anciens postes connus de Rui Jiang
Sociétés | Poste | Fin |
---|---|---|
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | Director/Board Member | 25/12/2020 |
Formation de Rui Jiang
Renmin University of China | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | Process Industries |
JINKO SOLAR CO., LTD. | Electronic Technology |
Entreprise privées | 1 |
---|---|
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Health Technology |